A nurse prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at the Northern General Hospital in Sheffield, UK, on December 8. Photo: AFP
A nurse prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at the Northern General Hospital in Sheffield, UK, on December 8. Photo: AFP
Sylvia Sheng
Opinion

Opinion

Sylvia Sheng

Vaccine optimism must be tempered with attention to coronavirus resurgence

  • While market sentiment has been dominated by hope that encouraging vaccine results will lead to economic recovery, the resurgence of the virus, especially in the US and Europe, means policy support must continue

A nurse prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at the Northern General Hospital in Sheffield, UK, on December 8. Photo: AFP
A nurse prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at the Northern General Hospital in Sheffield, UK, on December 8. Photo: AFP
READ FULL ARTICLE